Pirantel
Sold as Combantrin, Rid xtra worm
Every registration of this product has been cancelled.
1-Methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine
Drag to rotate. Structure from PubChem CID 708857.
Background
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Johnson & Johnson (Pty) Ltd û East LondonCancelled | Combantrin | oral suspension | D0260 | Not determined | None |
| The Premier Pharmaceutical Co LtdCancelled | Rid xtra worm | suspension | R0181 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Combantrin oral suspension EACH 5,0 ml SUSPENSION CONTAINS PIRANTEL PAMOATE 250,0 mg | Oral suspension | D0260D/12/260 | Cancelled | Not determined | None |
| Rid xtra worm suspension* EACH 5 ml SUSPENSION CONTAINS PIRANTEL PAMOATE EQUIVALENT TO PIRANTEL 250 mg | Suspension | R0181R/12/181 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.